Literature DB >> 8015857

Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies.

A el Bouhdidi1, C Truyens, M T Rivera, H Bazin, Y Carlier.   

Abstract

Trypanosoma cruzi infection in BALB/c mice induced a reversible polyisotypic hypergammaglobulinaemia, with particularly high levels of IgG2a, IgM and IgE. Hypergammaglobulinaemia started during the acute phase of infection and persisted during chronic disease until 11-13 weeks post-infection (w.p.i.), when immunoglobulin levels, with the exception of IgE, returned near normal values. Parasite-specific antibodies counted for 14 to 23% of gammaglobulinaemia, in acute and chronic infection respectively. The titres of IgM antibodies rose from two w.p.i. IgA, IgE and IgG subclass antibodies built up gradually over the time of parasite clearance (i.e., between three and six w.p.i.). All antibody isotypes, including IgM reached significant and stable titres throughout chronic infection. IgG2a, IgG1 and IgM antibodies had constantly higher titres than the other antibody isotypes. The dominance of IgG2a antibodies was due to their high plasma concentrations, around 70% of all antibodies available in the chronic infection. IgG1 had the highest functional avidity, whereas its concentration corresponded to only 10% of the whole antibody fraction. These results indicate that T. cruzi infection in mice induces a polyisotypic humoral immune response, dominated by some antibody isotypes, with major differences in concentrations and functional avidities. This could be of crucial importance in determining the outcome of infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015857     DOI: 10.1111/j.1365-3024.1994.tb00325.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  23 in total

1.  Trypanosoma cruzi activates cord blood myeloid dendritic cells independently of cell infection.

Authors:  Patricia Rodriguez; Yves Carlier; Carine Truyens
Journal:  Med Microbiol Immunol       Date:  2012-02-12       Impact factor: 3.402

2.  Biological and Molecular Characterization of Trypanosoma cruzi Strains from Four States of Brazil.

Authors:  Aline Rimoldi Ribeiro; Luciana Lima; Larissa Aguiar de Almeida; Joana Monteiro; Cláudia Jassica Gonçalves Moreno; Juliana Damieli Nascimento; Renato Freitas de Araújo; Fernanda Mello; Luciamáre Perinetti Alves Martins; Márcia Aparecida Silva Graminha; Marta Maria Geraldes Teixeira; Marcelo Sousa Silva; Mário Steindel; João Aristeu da Rosa
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

3.  Why does GM1 induce a potent beneficial response to experimental Chagas disease?

Authors:  S Cossy Isasi; C A Condat; G J Sibona
Journal:  HFSP J       Date:  2009-01-21

4.  Activation of cord blood myeloid dendritic cells by Trypanosoma cruzi and parasite-specific antibodies, proliferation of CD8+ T cells, and production of IFN-γ.

Authors:  Patricia Rodriguez; Yves Carlier; Carine Truyens
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

5.  CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.

Authors:  D Chaussabel; F Jacobs; J de Jonge; M de Veerman; Y Carlier; K Thielemans; M Goldman; B Vray
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

7.  Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses.

Authors:  C Truyens; A Angelo-Barrios; F Torrico; J Van Damme; H Heremans; Y Carlier
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

9.  IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.

Authors:  F Jacobs; D Chaussabel; C Truyens; V Leclerq; Y Carlier; M Goldman; B Vray
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  A Brucella virulence factor targets macrophages to trigger B-cell proliferation.

Authors:  Juan M Spera; Claudia K Herrmann; Mara S Roset; Diego J Comerci; Juan E Ugalde
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.